The 2017 Canadian opioid guideline: already time for an overhaul

The Canadian guideline’s[1][1] key recommendations are flawed. Based on three small studies on highly select patients,[2][2] the guideline recommends tapering for all patients taking dosages at or above 90 mg morphine equivalents daily regardless of their clinical response to the opioid. The